期刊文献+

中西医结合个体化联合序贯方案治疗IgA肾病的临床病理研究——附50例重复肾穿刺病理对照研究 被引量:12

Clinical and Pathological Observation of the Effect of Individualization Combined by Traditional Chinese Medicine and Western Medicine and Sequenced Therapy on IgA Nephrology
在线阅读 下载PDF
导出
摘要 目的 :研究中西医结合个体化联合序贯方案治疗IgA肾病的疗效及与病理的相关性。方法 :对 5 0例重复肾活检的IgAN患者进行不同治疗方案的临床与病理观察 ,Ⅰ组 2 7例采用中西医结合个体化联合序贯治疗 ,Ⅱ组2 3例未按个体化联合序贯治疗。结果 :Ⅰ组临床缓解率与显效率明显高于Ⅱ组 ;病理分析显示Ⅰ组治疗前后的Kata fuchi积分基本稳定 ,Ⅱ组则有显著升高 ,应用Andredi法分析显示Ⅰ组治疗后的活动性指数明显下降 ,而Ⅱ组治疗后的活动性指数与慢性指数均有明显上升。结论 :中西医结合个体化联合序贯方案不仅可提高IgAN临床缓解率 ,而且能显著降低肾脏的活动性病理指数 。 Objective:To study the effects of Individualization combined by Traditional Chinese Medicine(TCM) and Western Medicine(WM) and Sequenced Therapy(ST) on IgA nephrology.Methods:50 patients suffering from IgA nephrology were divided into two groups. 27 patients in group Ⅰ treated in Individualiztion combined by TCM and WM and ST. 23 patients in group Ⅱ treated in Non-individualiztion.Results:The clinical excellent effective rate in group Ⅰ was much higher than in group Ⅱ. The analysis on pathology showed that the integration of Katafuchi were steady in group Ⅰ but more increased in group Ⅱ, the acute index were obviously reduced in group Ⅰ but more increased in groupⅡ, and the chronic index were obviously increased in group Ⅱ.Conclusion:Not only Individualization Combined by Traditional Chinese Medicine and Western Medicine and Sequenced Therapy increase the clinical excellent effective rate in IgA nephropathy, but reduce the acute pathological scathe in kidney and delay the course of chronic progress.
出处 《中国中西医结合肾病杂志》 2004年第5期261-265,共5页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 浙江省科技厅基金资助项目 (No .11110 45 0 )
关键词 中西医结合 个体化治疗 序贯治疗 IGA肾病 临床病理 肾穿刺活检 IgA Nephropathy Repeat Renal Biopsy Individualization Combined by Traditional Chinese Medicine and Western Medicine and Sequenced Therapy
  • 相关文献

参考文献8

  • 1刘志红,黎磊石.IgA肾病的分型治疗[J].肾脏病与透析肾移植杂志,2002,11(1):43-44. 被引量:46
  • 2石晓云,陈香美,刘述文,庄永泽,张燕平.血管紧张素转换酶抑制剂对IgA肾病的疗效及影响因素分析[J].中华内科杂志,2002,41(6):399-403. 被引量:40
  • 3Schena FP.IgA Nephropathies.In:Cameron JS,Davison AM.Oxford Textbook of Clincal Neprology.Vol I,1st ed,Oxford.Oxford University Press,1922,339.
  • 4Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol,1998,49(1):1.
  • 5Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol,1989,3(3):248.
  • 6Kobayashi Y, Hiki Y, Kokabo T, et al. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron,1996,72(2):237.
  • 7Tsuruya K, Harada A, Hirakata H, et al. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.Clin Nephrol,2000,53(1):1.
  • 8Ballardie FW, Roberts IS.Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.J Am Soc Nephrol,2002,13(1):142.

二级参考文献10

  • 1Coppo R, Amore A, Gianoglio B,et al. Angiotensin Ⅱ local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis, 1993, 21:593-602.
  • 2Lee SM, Rao VM, Franklin WA, et al. IgA Nephropathy: morphologic predictors of progressive renal disease. Hum Pathol ,1982, 13:314-322.
  • 3Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol, 1998, 49:1-8.
  • 4Maschio G, Alberti D, Janin G, et al. Effecrt of the angiotensin-converting enzyme inhibitor benezepril on the progression of chronic renal insufficiency. The angiotensin-converting enzyme inhibition in progressive renal insufficiency study group. N Engl J Med ,1996, 334:939-945.
  • 5Dillon JJ. ACE inhibitor therapy for IgA nephropathy: a meta analysis. J Am Soc Nephrol ,1998, 9:86A.
  • 6Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition . Am J Kidney Dis, 1991, 17:330-338.
  • 7Myers BD, Meyer TW. Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy. Am J Kidney Dis, 1989, 13:20-24.
  • 8Don BR, Kaysen GA, Hutchison FN, et al. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis, 1991, 17:10-17.
  • 9Ikoma M, Kawamura T, Kakinuma Y, et al. Cause of variable therapeutic efficiency of angiotensin-converting enzyme inhibitors on glomerular lesions. Kidney Int, 1991, 40:195-202.
  • 10庄永泽,陈香美,张燕平,危成筠,石晓云,童新元,张高魁.540例IgA肾病高血压发生影响因素的分析[J].中华内科杂志,2000,39(6):371-375. 被引量:33

共引文献83

同被引文献106

引证文献12

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部